Q3 2014
Released Nov 13, 2014, after the close
10-Q filed Nov 13, 2014, 44 days after period end · 0001144204-14-067766
Q3 2014 · 10-Q
Revenue$491.00K$491.00K +17.5% vs Q3 2013+11.3% vs Q2 2014
Net Income$2.72M$2.72M N/M vs Q3 2013N/M vs Q2 2014
EPS Diluted-$0.02-$0.02 N/M vs Q3 2013N/M vs Q2 2014
Gross Profit$316,000+38.0%
Operating Income-$681,000N/M
Operating Cash Flowderived-$797,000N/M
Margins · derived
Gross margin64.4%+9.6 pt vs Q3 2013
Operating margin-138.7%+6.8 pt vs Q3 2013
Net margin554.6%+1130.7 pt vs Q3 2013
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $491.00K | $418.00K | $604.00K | $407.00K |
| Net Income | $2.72M | -$2.41M | -$853.00K | -$413.00K |
| EPS Diluted | -$0.02 | -$0.14 | -$0.07 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR